This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, O. M.
Right arrow Articles by Gelder, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, O. M.
Right arrow Articles by Gelder, C. M.

 Previous Article  |  Next Article 

Journal of Virology, August 2002, p. 7418-7429, Vol. 76, No. 15
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.15.7418-7429.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Analysis of CD4+ T-Cell Responses to Human Papillomavirus (HPV) Type 11 L1 in Healthy Adults Reveals a High Degree of Responsiveness and Cross-Reactivity with Other HPV Types

O. Martin Williams, Keith W. Hart, Eddie C. Y. Wang, and Colin M. Gelder*

Infection and Immunity, University of Wales College of Medicine, Cardiff CF14 4XX, Wales, United Kingdom

Received 14 December 2001/ Accepted 22 April 2002

Human papillomavirus type 11 (HPV-11) infection causes genital warts and recurrent respiratory papillomatosis. While there is compelling evidence that CD4+ T cells play an important role in immune surveillance of HPV-associated diseases, little is known about human CD4+ T-cell recognition of HPV-11. We have investigated the CD4+ T-cell responses of 25 unrelated healthy donors to HPV-11 L1 virus-like particles (VLP). CD4+ T-cell lines from 21 of 25 donors were established. Cell sorting experiments carried out on cells from six donors demonstrated that the response was located in the CD45RAlow CD45ROhigh memory T-cell population. To determine the peptide specificity of these responses, epitope selection was analyzed by using 95 15-mer peptides spanning the entire HPV-11 L1 protein. No single region of L1 was immunodominant; responders recognized between 1 and 10 peptides, located throughout the protein, and peptide responses fell into clear HLA class II restricted patterns. Panels of L1 peptides specific for skin and genital HPV were used to show that the L1 CD4+ T-cell responses were cross-reactive. The degree of cross-reactivity was inversely related to the degree of L1 sequence diversity between these viruses. Finally, responses to HPV-11 L1 peptides were elicited from ex vivo CD45RO+ peripheral blood mononuclear cells, demonstrating that recognition of HPV-11 was a specific memory response and not due to in vitro selection during tissue culture. This is the first study of CD4+ T-cell responses to HPV-11 in healthy subjects and demonstrates marked cross-reactivity with other skin and genital HPV types. This cross-reactivity may be of significance for vaccine strategies against HPV-associated clinical diseases.


* Corresponding author. Mailing address: Infection and Immunity, Tenovus Building, University of Wales College of Medicine, Heath Park, Cardiff CF14 2XX, Wales, United Kingdom. Phone: 44-29-20742579. Fax: 44-29-20745003. E-mail: Viralimmunol{at}cf.ac.uk.


Journal of Virology, August 2002, p. 7418-7429, Vol. 76, No. 15
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.15.7418-7429.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Xi, L. F., Edelstein, Z. R., Meyers, C., Ho, J., Cherne, S. L., Schiffman, M. (2009). Human Papillomavirus Types 16 and 18 DNA Load in Relation to Coexistence of Other Types, Particularly Those in the Same Species. Cancer Epidemiol. Biomarkers Prev. 18: 2507-2512 [Abstract] [Full Text]  
  • Smith, K. L., Tristram, A., Gallagher, K. M., Fiander, A. N., Man, S. (2005). Epitope specificity and longevity of a vaccine-induced human T cell response against HPV18. Int Immunol 17: 167-176 [Abstract] [Full Text]  
  • Ho, G. Y. F., Studentsov, Y. Y., Bierman, R., Burk, R. D. (2004). Natural History of Human Papillomavirus Type 16 Virus-Like Particle Antibodies in Young Women. Cancer Epidemiol. Biomarkers Prev. 13: 110-116 [Abstract] [Full Text]  
  • Davidson, E. J., Sehr, P., Faulkner, R. L., Parish, J. L., Gaston, K., Moore, R. A., Pawlita, M., Kitchener, H. C., Stern, P. L. (2003). Human papillomavirus type 16 E2- and L1-specific serological and T-cell responses in women with vulval intraepithelial neoplasia. J. Gen. Virol. 84: 2089-2097 [Abstract] [Full Text]  
  • Gelder, C. M., Williams, O. M., Hart, K. W., Wall, S., Williams, G., Ingrams, D., Bull, P., Bunce, M., Welsh, K., Marshall, S. E. F., Borysiewicz, L. (2003). HLA Class II Polymorphisms and Susceptibility to Recurrent Respiratory Papillomatosis. J. Virol. 77: 1927-1939 [Abstract] [Full Text]